[On the use of prodigiosan in combination with antibiotics for the treatment of acute and chronic inflammatory diseases of the cerebral membranes].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001100:Arachnoiditis / Q000188:drug therapy*; D001922:Brain Abscess / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D008875:Middle Aged; D009761:Nystatin / Q000627:therapeutic use; D010019:Osteomyelitis / Q000188:drug therapy*; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D012706:Serratia marcescens; D013118:Spinal Cord Diseases / Q000188:drug therapy*; D013307:Streptomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D011135:Polysaccharides, Bacterial; D009761:Nystatin; D013307:Streptomycin
O primenenii prodigiozana v sochetanii s antibiotikami dlia lecheniia ostrykh i khronicheskikh vospalitel'nykh mozgovykh obolochek.